(Q37097051)

18 August 2017

0 references

1 reference

title

The Reten-World survey of the management of acute urinary retention: preliminary results (English)

1 reference

18 August 2017

1

Mark Emberton

1 reference

18 August 2017

John M Fitzpatrick

2

1 reference

18 August 2017

publication date

1 March 2008

1 reference

18 August 2017

1 reference

18 August 2017

volume

101 Suppl 3

1 reference

18 August 2017

page(s)

27-32

1 reference

Acute urinary retention in men: an age old problem

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07491.X

Acute urinary retention: what is the impact on patients' quality of life?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07491.X

Low incidence of acute urinary retention in the general male population: the triumph project

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07491.X

Incidence of primary and recurrent acute urinary retention between 1998 and 2003 in England.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07491.X

Urinary retention in patients with BPH treated with finasteride or placebo over 4 years. Characterization of patients and ultimate outcomes. The PLESS Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07491.X

The management of acute urinary retention in France: a cross-sectional survey in 2618 men with benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07491.X

Distribution of post-void residual urine volume in randomly selected men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07491.X

Symptom deterioration during treatment and history of AUR are the strongest predictors for AUR and BPH-related surgery in men with LUTS treated with alfuzosin 10 mg once daily

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07491.X

Response to daily 10 mg alfuzosin predicts acute urinary retention and benign prostatic hyperplasia related surgery in men with lower urinary tract symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07491.X

Alfuzosin once daily facilitates return to voiding in patients in acute urinary retention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07491.X

Sustained-release alfuzosin and trial without catheter after acute urinary retention: a prospective, placebo-controlled.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07491.X

The role of alpha-blockers in the management of acute urinary retention caused by benign prostatic obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07491.X

Alfuzosin 10 mg once daily in the management of acute urinary retention: results of a double-blind placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07491.X

Management of acute urinary retention secondary to benign prostatic hyperplasia in the UK: a national survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07491.X

Mortality in men admitted to hospital with acute urinary retention: database analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07491.X

10.1111/J.1464-410X.2008.07491.X

21 January 2018

Identifiers

DOI

1 reference

18 August 2017

1 reference